SRPT
#1941
Sarepta Therapeutics, Inc. - Common Stock
20.8 6 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.38%
Monthly Change
+34.23%
6 month change
+28.69%
Year Change
+15.57%
Previous Close
21.5 9
Open
20.8 6
Low
20.8 6
High
20.8 6
Volume
247
Financials
- Market Capitalization 2.2 B
- Employee 835
- Founded 1980
- CEO Douglas S. Ingram
- Website www.sarepta.com
- Headquarter Delaware, United States
- FIGI BBG000BCJ161
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.02
Price to sales ratio
0.98
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1923 |  MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.60 USD | -1.58% | -0.31% | -1.88% | -36.59% | 2.26 B USD | ||
| 1924 |  MESO Mesoblast Limited - American Depositary Shares | 17.44 USD | -4.07% | +3.81% | +21.79% | +33.64% | 2.26 B USD | ||
| 1948 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.29 USD | -1.15% | -1.69% | +7.88% | +36.55% | 2.17 B USD | ||
| 1961 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 43.62 USD | -4.13% | -6.76% | +8.18% | +129.58% | 2.13 B USD |
Frequently asked questions about Sarepta Therapeutics,, Inc. Common Stock
What is the Sarepta Therapeutics,, Inc. Common Stock stock price today?
The current price of Sarepta Therapeutics,, Inc. Common Stock (SRPT) is 20.86. Over the past 24 hours, the stock has changed by -3.38%. Follow the SRPT chart for real-time price dynamics.
What is the stock ticker of Sarepta Therapeutics,, Inc. Common Stock?
Sarepta Therapeutics,, Inc. Common Stock trades under the ticker SRPT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Sarepta Therapeutics,, Inc. Common Stock stock going up?
SRPT has changed by +12.39% over the last week, +34.23% over the last month, and +15.57% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Sarepta Therapeutics,, Inc. Common Stock?
Sarepta Therapeutics,, Inc. Common Stock currently has a market capitalization of 2.2 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Sarepta Therapeutics,, Inc. Common Stock earnings last quarter?
Last quarter, Sarepta Therapeutics,, Inc. Common Stock reported earnings of -0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Sarepta Therapeutics,, Inc. Common Stock revenue for the last quarter?
Sarepta Therapeutics,, Inc. Common Stock reported quarterly revenue of 401.25 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Sarepta Therapeutics,, Inc. Common Stock net income for the last quarter?
Sarepta Therapeutics,, Inc. Common Stock reported net income of -4.89 M for the last quarter. The previous quarter showed 330.96 M, which means net income changed by -101.48%.
How many employees does Sarepta Therapeutics,, Inc. Common Stock have?
As of the latest available data, Sarepta Therapeutics,, Inc. Common Stock has 835 employees. Workforce size can provide additional context about the company's scale and operations.
What is Sarepta Therapeutics,, Inc. Common Stock EBITDA?
Sarepta Therapeutics,, Inc. Common Stock EBITDA is 23.7 M, and its EBITDA margin is 5.91%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Sarepta Therapeutics,, Inc. Common Stock stock?
You can buy Sarepta Therapeutics,, Inc. Common Stock (SRPT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Sarepta Therapeutics,, Inc. Common Stock stock?
Investing in Sarepta Therapeutics,, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SRPT chart and related analysis on metatrader.com as part of your research.